Haisco Pharmaceutical Group Co., Ltd.
Haisco Pharmaceutical Group Co., Ltd.
Explore linked clinical trials.50 results · Page 1 of 2
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Phase 3 Study Evaluating the Safety and Efficacy of HSK31679 in Patients With MASH | Digestive System Diseases, fatty liver disease, liver disorder, metabolic dysfunction-associated steatotic liver disease | Recruiting | Phase 3 | 2026-09-23 | NCT07581951 | |
| HSK42360-Na Tablets Combined With Cetuximab With or Without Chemotherapy in BRAF V600-Mutant Metastatic Colorectal Cancer | Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, colonic disorder, colorectal neoplasm, digestive system disorder, digestive system neoplasm, intestinal disorder, neoplasm, rectal disorder | Recruiting | Phase 1 / Phase 2 | 2026-08-27 | NCT07790510 | |
| Evaluating the Efficacy and Safety of of HSK50042 in People With Idiopathic Pulmonary Fibrosis | idiopathic pulmonary fibrosis, interstitial lung disease, lung disorder, pulmonary fibrosis, respiratory system disorder | Not yet recruiting | Phase 2 | 2026-07-27 | NCT07728721 | |
| HSK41959 With Standard Therapy in Solid Tumors With MTAP Deletion | Neoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, lung disorder, lung neoplasm, neoplasm, non-small cell lung carcinoma, respiratory system disorder, respiratory tract neoplasm | Not yet recruiting | Phase 1 | 2026-07-14 | NCT07699757 | |
| Ciprofol vs Propofol for Hemodynamic Stability in Patients Having General Anesthesia for Endovascular Thrombectomy After Ischemic Stroke | brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, ischemic stroke, nervous system disorder, stroke disorder, vascular disorder | Not yet recruiting | Phase 4 | 2026-07-10 | NCT07696208 | |
| A Phase 1 Study to Evaluate the Safety, Tolerability, and Pharmacokinetics/Pharmacodynamics of HSK46256 in Patients With Advanced Solid Tumors | Advanced Solid Tumor (Phase 1) | Not yet recruiting | Phase 1 | 2026-07-10 | NCT07695142 | |
| Preventive Analgesia With Anrikefon in Laparoscopic Cholecystectomy | Neurologic Manifestations, Nociceptive Pain, Pain, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Postoperative Complications, Postoperative Pain, Signs and Symptoms, Visceral Pain | Recruiting | Not applicable | 2026-07-01 | NCT07566663 | |
| First-in-human Study of HSK56630 in Healthy Subjects | Healthy Volunteer | Recruiting | Phase 1 | 2026-06-24 | NCT07580794 | |
| A Phase 3 Clinical Trial to Evaluate the Safety and Efficacy of HSK39004 Inhalation Suspension in Patients With COPD | Chronic Disease, Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, chronic obstructive pulmonary disease, lung disorder, obstructive lung disease, respiratory system disorder | Not yet recruiting | Phase 3 | 2026-06-22 | NCT07658339 | |
| A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Phase III Study of HSK39004 Inhalation Powder for the Treatment of COPD | Chronic Disease, Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, chronic obstructive pulmonary disease, lung disorder, obstructive lung disease, respiratory system disorder | Recruiting | Phase 3 | 2026-06-10 | NCT07583849 | |
| Evaluation of the Safety and Efficacy of HSK39004 Dry Powder Inhaler and HSK39004 Inhalation Suspension in Chinese Patients With Chronic Obstructive Pulmonary Disease (COPD) | Chronic Disease, Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, chronic obstructive pulmonary disease, lung disorder, obstructive lung disease, respiratory system disorder | Recruiting | Phase 2 | 2026-06-09 | NCT07140328 | |
| Long-Term Safety and Efficacy of HSK39004 Inhalation Suspension in COPD | Chronic Disease, Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, chronic obstructive pulmonary disease, lung disorder, obstructive lung disease, respiratory system disorder | Not yet recruiting | Phase 3 | 2026-06-08 | NCT07634367 | |
| Trial of HSK44459 Cream for the Management Plaque Psoriasis | Skin Diseases, Papulosquamous, Skin and Connective Tissue Diseases, psoriasis, skin disorder | Active, not recruiting | Phase 1 / Phase 2 | 2026-06-08 | NCT07623486 | |
| A Study to Evaluate the Long-Term Safety and Efficacy of HSK39297 Tablets in Primary IgA Nephropathy | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, IgA glomerulonephritis, Male Urogenital Diseases, Urogenital Diseases, autoimmune disease, glomerulonephritis, immune system disorder, kidney disorder, nephritis, urinary system disorder | Recruiting | Phase 2 | 2026-06-01 | NCT07616700 | |
| A Study to Assess the Safety of HSK31858 in Participants With Non-Cystic Fibrosis Bronchiectasis | Non-cystic Fibrosis Bronchiectasis | Recruiting | Phase 3 | 2026-06-01 | NCT07616375 | |
| A Clinical Trial Evaluating the Efficacy and Safety of HSK55718 in Patients for Postoperative Pain Treatment in Abdominal Surgery | Pain After Surgery | Recruiting | Phase 2 | 2026-05-28 | NCT07533786 | |
| Phase Ⅲ Study of Efficacy and Safety of HSK39297 Tablet in Treatment of Patients With Primary IgAN | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, IgA glomerulonephritis, Male Urogenital Diseases, Urogenital Diseases, autoimmune disease, glomerulonephritis, immune system disorder, kidney disorder, nephritis, urinary system disorder | Recruiting | Phase 3 | 2026-05-28 | NCT07390123 | |
| Phase I Study of HSK42360-Na in Solid Tumors With BRAF V600 Mutation | Solid Tumors (Phase 1) | Recruiting | Phase 1 | 2026-05-01 | NCT07561554 | |
| A Clinical Trial Evaluating the Efficacy and Safety of HSK55718 in Patients for Postoperative Pain Treatment in Orthopedic Surgery | Pain After Surgery | Not yet recruiting | Phase 2 | 2026-04-27 | NCT07551739 | |
| A Phase I Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and the Food Effect of HSK55879 Tablets in Healthy Subjects. | Healhty | Recruiting | Phase 1 | 2026-04-09 | NCT07521345 | |
| A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase III Study to Evaluate the Efficacy and Safety of HSK44459 Tablets in Patients With Idiopathic Pulmonary Fibrosis | idiopathic pulmonary fibrosis | Not yet recruiting | Phase 3 | 2026-04-09 | NCT07519070 | |
| Evaluation of the Safety and Efficacy of HSK39004 Dry Powder Inhaler in Chinese Patients With Chronic Obstructive Pulmonary Disease (COPD) | Chronic Disease, Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, chronic obstructive pulmonary disease, lung disorder, obstructive lung disease, respiratory system disorder | Active, not recruiting | Phase 2 | 2026-04-08 | NCT07108699 | |
| HSK3486 (Cipepofol) Injectable Emulsion for Induction of General Anesthesia in Pediatric Subjects Undergoing Elective Surgery | General Anesthetic | Not yet recruiting | Phase 3 | 2026-04-06 | NCT07510945 | |
| Evaluating the Efficacy and Safety of of HSK44459 in People With Progressive Pulmonary Fibrosis | Progressive Pulmonary Fibrosis | Not yet recruiting | Phase 3 | 2026-03-31 | NCT07503587 | |
| A Study for HSK47388 in Participants With Ulcerative Colitis | Digestive System Diseases, colitis, colonic disorder, digestive system disorder, gastroenteritis, inflammatory bowel disease, intestinal disorder, ulcerative colitis | Recruiting | Phase 2 | 2026-03-05 | NCT07335055 |